Delayed effects of radiation exposure in a C57L/J mouse model of partial body irradiation with ~2.5% bone marrow shielding
Bibliographic Data
| ID | 22080589 |
|---|---|
| Authors | Tyler Beach, Tyler A Beach (0000-0002-3859-9288, SRI International), James Bakke (SRI International), J Tyson McDonald (0000-0003-4300-6827), Jackie McDonald (0000-0003-1955-6052, SRI International), Edward Riccio, Edward S Riccio (SRI International), Harold S Javitz (0000-0002-6370-174X, SRI International), Denise Nishita (SRI International), Shweta Kapur (SRI International), Deborah I Bunin (SRI International), Polly Y Chang (0000-0002-1324-5408, SRI International, corresponding author) |
| Year | 2024 |
| Volume | 12 |
| Pages | 1349552-1349552 |
| Publication date | 2024-03-12 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Public Health (JOURNAL) |
| Journal identifiers | ISSN: 2296-2565 • E-ISSN: 2296-2565 |
| Publisher | Frontiers Media SA (PUBLISHER • CH) |
| DOI | 10.3389/fpubh.2024.1349552 |
| PMID | 38544733 |
| OpenAlex | W4392712550 |
| Language | EN |
| References cited | 22 |
Introduction: Mouse models of radiation injury are critical to the development of medical countermeasures (MCMs) against radiation. Now that MCMs against hematopoietic acute radiation syndrome (H-ARS) have achieved regulatory approval, attention is shifting to develop MCMs against the adverse effects of gastrointestinal acute radiation syndrome (GI-ARS) and delayed effects of acute radiation exposure (DEARE). The C57L/J mouse model of partial body irradiation (PBI) with 2.5% bone marrow shielding (BM2.5) is being leveraged to examine both GI-ARS and DEARE effects. Within days of PBI, mice may develop H- and GI-ARS followed several months later by DEARE as a multi-organ injury, which typically involves the lung and kidney (L- and K-DEARE, respectively). The objective of this manuscript is to describe the dose response relationship and progression of radiation injury in the C57L/J mouse and to evaluate its suitability for use in DEARE MCM testing. Materials and methods: In two separate studies conducted over 2 years, male and female C57L/J mice were exposed to PBI BM2.5 with one hindlimb shielded from radiation, representing ~2.5% bone marrow shielding/sparing. Mice were X-ray irradiated at doses ranging from 9 to 13 Gy at 10 to 12 weeks of age for the purposes of assessing ARS survival at 30 days and DEARE survival at 182 days post-irradiation. Clinical indicators of ARS and DEARE were determined by clinical observations, body weights, hematology, clinical chemistry, magnetic resonance imaging (MRI) of lung, and histopathology of selected tissues. Results: C57L/J mice developed canonical ARS responses of hematopoietic atrophy and gastrointestinal injury resulting in dose dependent mortality at doses ≥11 Gy between 1- and 15-days post-irradiation. In animals that survived ARS, DEARE associated mortality occurred in dose dependent fashion at ≥9 Gy for both sexes between 60- and 159-days post-irradiation with histopathology examinations indicating lung injury as the primary cause of death in moribund animals. Conclusion: The PBI BM2.5 C57L/J mouse model reliably produced known H- and GI-ARS effects at doses greater than those resulting in DEARE effects. Because of this, the C57L/J mouse can be used to test MCMs against L-DEARE injury, while avoiding ARS associated mortality
Bone marrow · Composite material · Electromagnetic shielding · Irradiation · Nuclear medicine · Optics · Pathology · Physics · Radiation exposure · Radiation injury · Radiation shielding · Radiation therapy · Radiology · Whole body irradiation · Effects of Radiation Exposure · Immune Response and Inflammation · Materials Science · Medicine · Radiation Dose and Imaging · Cancer Research · Radiation
| Highly cited | No |
|---|